The Yale chapter of Delta Sigma Theta Sorority, Inc. recently engaged the community with a week-long series of events known as the “REDaissance,” celebrating its annual...
On October 14, 2023, community members gathered for a food drive organized by SOS, Inc. in partnership with Walmart, successfully collecting essential items to assist families...
Castle Biosciences, Inc. has announced significant findings regarding its TissueCypher® Barrett’s Esophagus test, which offers crucial insights into patient risk that extend beyond traditional pathology. The...
Cogent Biosciences, Inc. has presented updated preclinical data on its pan KRAS(ON) inhibitor during a poster session at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets...
Cardio Diagnostics Holdings, Inc. has announced a significant expansion of its provider network, adding 15 new medical organizations from various regions across the United States. This...
Spero Therapeutics, Inc. and GSK plc have announced promising results from the pivotal Phase 3 PIVOT-PO trial for **tebipenem HBr**, an investigational oral antibiotic aimed at...
SpringWorks Therapeutics, Inc. has published new long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat). This oral gamma secretase inhibitor is...
Moderna, Inc. has announced promising early results from its investigational cancer therapy, mRNA-4359. This data will be presented at the 2025 European Society for Medical Oncology...
The recent “Trenton Plates, The World Takes” event, organized by Cross Community, Inc. and Rise Against Hunger, saw a significant contribution from students at Christina Seix...
Penumbra, Inc., a leading company in thrombectomy technology, announced it will host an investor event on October 26, 2025, during the 2025 Transcatheter Cardiovascular Therapeutics (TCT)...
